Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes

Blood Cancer J. 2017 Sep 1;7(9):e602. doi: 10.1038/bcj.2017.82.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Black or African American / genetics*
  • Class I Phosphatidylinositol 3-Kinases / genetics*
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Mutation*
  • Myelodysplastic Syndromes / epidemiology
  • Myelodysplastic Syndromes / genetics*
  • Tumor Suppressor Protein p53 / genetics*
  • United States / epidemiology
  • White People / genetics*

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human